KENDALL CAPITAL MANAGEMENT – Regeneron Pharmaceuticals, Inc. Transaction History
KENDALL CAPITAL MANAGEMENT portfolio value:
$1.73M
portfolio value
KENDALL CAPITAL MANAGEMENT quarter portfolio value change:
+16.53%
quarter
Regeneron Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -0.36% | -9 shares | 241K | $688.87 | 2.51K |
| Q2 2022 | share | Increase | +10.20% | 234 shares | -107K | $591.13 | 2.52K |
| Q1 2022 | share | Increase | +0.44% | 10 shares | 159K | $698.42 | 2.29K |
| Q4 2021 | share | Decrease | -3.06% | -72 shares | 17K | $642.51 | 2.28K |
| Q3 2021 | share | Decrease | -1.79% | -43 shares | 86K | $605.18 | 2.35K |
| Q2 2021 | share | 0.00% | 0 shares | 204K | $558.54 | 2.39K | |
| Q1 2021 | share | Increase | +5.36% | 122 shares | 35K | $473.14 | 2.39K |
| Q4 2020 | share | Increase | +5.08% | 110 shares | -112K | $483.11 | 2.27K |
| Q3 2020 | share | Decrease | -3.35% | -75 shares | -186K | $559.78 | 2.16K |
| Q2 2020 | share | Decrease | -3.03% | -70 shares | 270K | $623.65 | 2.24K |
| Q1 2020 | share | Decrease | -6.66% | -165 shares | 198K | $488.29 | 2.31K |
| Q4 2019 | share | Increase | +24.23% | 483 shares | 377K | $375.48 | 2.47K |
| Q3 2019 | share | Increase | +14.34% | 250 shares | 7K | $277.4 | 1.99K |
| Q2 2019 | share | Increase | +31.15% | 414 shares | 0 | $313 | 1.74K |
| Q1 2019 | share | Increase | +54.90% | 471 shares | 226K | $410.62 | 1.32K |
| Q4 2018 | share | Increase | +28.25% | 189 shares | 50K | $373.5 | 858 |
| Q3 2018 | share | Increase | 0.00% | 669 shares | 270K | $404.04 | 669 |